Assistant Professor Ahmar Zaidi - The Current Therapeutic Landscape of Sickle Cell Disease

Sickle Cell Disease is a debilitating genetic disease. Currently only four drugs have been approved by the US FDA (hydroxyurea, L-glutamine, crizanlizumab and voxelotor) for the treatment of Sickle Cell Disease. We were honored to have Assistant Professor Ahmar Zaidi of Children's Hospital of Michigan ( Hematology and Oncology) as our guest speaker. He presented on the topic "The current therapeutic landscape of sickle cell disease". See it here. #SickleCellDisease #Awareness #SCDEducation #TeamASCA #ConquerSCD